Barclays’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.52M | Buy |
884,340
+313,504
| +55% | +$540K | ﹤0.01% | 2407 |
|
2025
Q1 | $1.9M | Sell |
570,836
-46,967
| -8% | -$156K | ﹤0.01% | 2065 |
|
2024
Q4 | $4.57M | Buy |
617,803
+13,219
| +2% | +$97.8K | ﹤0.01% | 1667 |
|
2024
Q3 | $5.68M | Buy |
604,584
+328,284
| +119% | +$3.08M | ﹤0.01% | 1443 |
|
2024
Q2 | $2.22M | Buy |
276,300
+20,947
| +8% | +$168K | ﹤0.01% | 1632 |
|
2024
Q1 | $3.78M | Sell |
255,353
-580,822
| -69% | -$8.6M | ﹤0.01% | 1523 |
|
2023
Q4 | $6.8M | Buy |
836,175
+78,224
| +10% | +$636K | ﹤0.01% | 1287 |
|
2023
Q3 | $3.45M | Buy |
757,951
+228,359
| +43% | +$1.04M | ﹤0.01% | 1345 |
|
2023
Q2 | $3.73M | Buy |
529,592
+112,432
| +27% | +$792K | ﹤0.01% | 1383 |
|
2023
Q1 | $2.55M | Sell |
417,160
-213,790
| -34% | -$1.31M | ﹤0.01% | 1489 |
|
2022
Q4 | $4.03M | Buy |
630,950
+240,344
| +62% | +$1.54M | ﹤0.01% | 1229 |
|
2022
Q3 | $3.74M | Buy |
390,606
+347,191
| +800% | +$3.33M | ﹤0.01% | 1264 |
|
2022
Q2 | $479K | Sell |
43,415
-29,849
| -41% | -$329K | ﹤0.01% | 2605 |
|
2022
Q1 | $1.22M | Buy |
73,264
+67,312
| +1,131% | +$1.12M | ﹤0.01% | 2153 |
|
2021
Q4 | $114K | Sell |
5,952
-24,938
| -81% | -$478K | ﹤0.01% | 2937 |
|
2021
Q3 | $761K | Sell |
30,890
-59,373
| -66% | -$1.46M | ﹤0.01% | 2392 |
|
2021
Q2 | $2.35M | Buy |
90,263
+21,869
| +32% | +$569K | ﹤0.01% | 1625 |
|
2021
Q1 | $2.17M | Buy |
68,394
+1,821
| +3% | +$57.7K | ﹤0.01% | 1794 |
|
2020
Q4 | $3.09M | Buy |
66,573
+7,617
| +13% | +$354K | ﹤0.01% | 1304 |
|
2020
Q3 | $1.94M | Sell |
58,956
-133,423
| -69% | -$4.39M | ﹤0.01% | 1515 |
|
2020
Q2 | $5.28M | Buy |
192,379
+70,563
| +58% | +$1.94M | ﹤0.01% | 907 |
|
2020
Q1 | $3.65M | Sell |
121,816
-87,865
| -42% | -$2.63M | ﹤0.01% | 1017 |
|
2019
Q4 | $5.8M | Buy |
209,681
+104,169
| +99% | +$2.88M | ﹤0.01% | 1121 |
|
2019
Q3 | $1.92M | Buy |
105,512
+30,578
| +41% | +$557K | ﹤0.01% | 1792 |
|
2019
Q2 | $1.84M | Buy |
74,934
+18,906
| +34% | +$464K | ﹤0.01% | 1882 |
|
2019
Q1 | $534K | Buy |
+56,028
| New | +$534K | ﹤0.01% | 2571 |
|
2018
Q4 | – | Sell |
-47,860
| Closed | -$539K | – | 4220 |
|
2018
Q3 | $539K | Buy |
47,860
+34,846
| +268% | +$392K | ﹤0.01% | 2596 |
|
2018
Q2 | $167K | Sell |
13,014
-4,247
| -25% | -$54.5K | ﹤0.01% | 2827 |
|
2018
Q1 | $291K | Sell |
17,261
-18,538
| -52% | -$313K | ﹤0.01% | 2620 |
|
2017
Q4 | $286K | Buy |
35,799
+32,563
| +1,006% | +$260K | ﹤0.01% | 2448 |
|
2017
Q3 | $25K | Buy |
3,236
+3,196
| +7,990% | +$24.7K | ﹤0.01% | 3151 |
|
2017
Q2 | $0 | Sell |
40
-1,417
| -97% | – | ﹤0.01% | 3962 |
|
2017
Q1 | $11K | Sell |
1,457
-1,212
| -45% | -$9.15K | ﹤0.01% | 3510 |
|
2016
Q4 | $18K | Sell |
2,669
-12,437
| -82% | -$83.9K | ﹤0.01% | 3118 |
|
2016
Q3 | $124K | Sell |
15,106
-61,821
| -80% | -$507K | ﹤0.01% | 2351 |
|
2016
Q2 | $623K | Buy |
76,927
+76,632
| +25,977% | +$621K | ﹤0.01% | 1652 |
|
2016
Q1 | $1K | Sell |
295
-509
| -63% | -$1.73K | ﹤0.01% | 3299 |
|
2015
Q4 | $5K | Buy |
804
+569
| +242% | +$3.54K | ﹤0.01% | 2910 |
|
2015
Q3 | $1K | Sell |
235
-626
| -73% | -$2.66K | ﹤0.01% | 3709 |
|
2015
Q2 | $8K | Buy |
+861
| New | +$8K | ﹤0.01% | 3389 |
|